Westlake BioPartners Fund I, L.P.'s Form 4 filing
Kyverna Therapeutics, Inc. (KYTX) · filed Dec 22, 2025
- Accession no.
- 0001104659-25-123596
- Filed
- Dec 22, 2025, 11:42 AM ET
- Trade date
- Dec 18, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $1.00M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Westlake BioPartners Fund I, L.P.CIK 0001749591 | 10% Owner |
| Westlake BioPartners Opportunity GP I, LLCCIK 0001811945 | 10% Owner |
| Westlake BioPartners Opportunity Fund I, L.P.CIK 0001811946 | 10% Owner |
| Westlake BioPartners GP I, LLCCIK 0002007650 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 18, 2025 | Common Stock | PPurchaseAcquired | +133,333 | $7.50 | +$999,997.5 | 869,317 | Indirect | Duplicate filing |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.